New Advances in the pharmacological management of Heart Failure

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorPai, Hui Hsuan
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentMegyeri, Attila
dc.contributor.opponentdeptKenézy Kórház, Aneszteziológiai és Intenziv Therápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-01-27T10:00:56Z
dc.date.available2022-01-27T10:00:56Z
dc.date.created2021-04-13
dc.description.abstractWith its staggering incidence and prevalence world-wide, HF remains arguably the greatest unmet therapeutic need in cardiovascular medicine nowadays. Even with the advancements in SOC (standard of care) programs, mortality and morbidity is yet to be restrained. This then perpetuates the idea of an urgent call for advancement in the current pharmacological management entity. Besides, with the progress made on clarifying the pathogenesis of HF other than the notorious neuro-hormonal pathway, we now have plenty as plausible therapy targets. Which is why this thesis will focus on the advancements already made in pharmacological aspects of HF management and briefly discuss some of the plausible treatment entities.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent42hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/328222
dc.language.isoenhu_HU
dc.subjectheart failurehu_HU
dc.subjectpharmacological management
dc.subjectnew advances
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleNew Advances in the pharmacological management of Heart Failurehu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)